Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

December 20, 2024 13:15 ET | Source: Syntekabio USA Inc.

Syntekabio to Showcase AI-Driven Drug Discovery Solutions at Biotech Showcase 2025

NEW YORK, Dec. 20, 2024 (GLOBE NEWSWIRE) -- Syntekabio (KOSDAQ: 226330), a leading artificial intelligence (AI)-driven drug development company, is pleased to announce its participation in Biotech...
June 20, 2024 10:00 ET | Source: Syntekabio USA Inc.

Syntekabio Signs Memorandum of Understanding with bioSeedin/ACROBiosystems

DAEJEON, South Korea, June 20, 2024 (GLOBE NEWSWIRE) -- Syntekabio (KOSDAQ: 226330), an artificial intelligence (AI) based drug development company, announced the signing of a strategic Memorandum...
May 23, 2024 10:00 ET | Source: Syntekabio USA Inc.

Syntekabio to Showcase Advanced AI Drug Discovery Technologies at BIO International Convention 2024

NEW YORK, May 23, 2024 (GLOBE NEWSWIRE) -- Syntekabio (226330.KQ), a global artificial intelligence (AI) drug discovery pioneer, today announced its participation at the BIO International Convention...
May 07, 2024 10:30 ET | Source: Syntekabio USA Inc.

Syntekabio to Showcase Biologics Discovery Platform at PEGS Boston

NEW YORK, May 07, 2024 (GLOBE NEWSWIRE) -- Syntekabio (226330.KQ), a global artificial intelligence (AI) drug discovery pioneer, today announced its participation at the 20th Annual PEGS Boston –...
April 11, 2024 10:15 ET | Source: Syntekabio USA Inc.

Syntekabio to Showcase Innovative AI Drug Discovery Technologies at Bio-IT World

NEW YORK, April 11, 2024 (GLOBE NEWSWIRE) -- Syntekabio (226330.KQ), a global artificial intelligence (AI) drug discovery pioneer, today announced its participation at the upcoming Bio-IT World...
September 26, 2022 15:07 ET | Source: Syntekabio

Syntekabio (KOSDAQ:226330.KQ) Presents Neoantigen Prediction Technology at Cancer Immunotherapy Conference CICON22

New York, N.Y., United States, Sept. 26, 2022 (GLOBE NEWSWIRE) -- Syntekabio (KOSDAQ:226330.KQ), a global AI drug discovery and development company, will present its neoantigen prediction technology...